Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children
Open accessThe DOI matches its Crossref record; 244 of the 246 references it cites were found in a registry or an index.
Abstract
Background.: Individuals infected with Mycobacterium tuberculosis (Mtb) may develop symptoms and signs of disease (tuberculosis disease) or may have no clinical evidence of disease (latent tuberculosis infection [LTBI]). Tuberculosis disease is a leading cause of infectious disease morbidity and mortality worldwide, yet many questions related to its diagnosis remain. Methods.: A task force supported by the American Thoracic Society, Centers for Disease Control and Prevention, and Infectious Diseases Society of America searched, selected, and synthesized relevant evidence. The evidence was then used as the basis for recommendations about the diagnosis of tuberculosis disease and LTBI in adults and children. The recommendations were formulated, written, and graded using the Grading, Recommendations, Assessment, Development and Evaluation (GRADE) approach. Results.: Twenty-three evidence-based recommendations about diagnostic testing for latent tuberculosis infection, pulmonary tuberculosis, and extrapulmonary tuberculosis are provided. Six of the recommendations are strong, whereas the remaining 17 are conditional. Conclusions.: These guidelines are not intended to impose a standard of care. They provide the basis for rational decisions in the diagnosis of tuberculosis in the context of the existing evidence. No guidelines can take into account all of the often compelling unique individual clinical circumstances.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, culture may lead to misclassification of some cases of extrapulmonary tuberculosis as ‘not tuberculosis', owing to the paucibacillary nature of the disease.”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Lewinsohn 2017
In the citing paper
“This means that culture may have low sensitivity for extrapulmonary tuberculosis overall and further that culture sensitivity may differ for different forms of extrapulmonary tuberculosis (Lewinsohn 2017).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Lewinsohn 2017
In the citing paper
“A recent evidence synthesis reported sensitivities of 72% to 88% in lymph node tissue, 28% to 81% in pleural fluid, 90% in pleural tissue, and 31% to 56% in CSF. Specificity ranged from 90% to 100% (Lewinsohn 2017).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Lewinsohn 2017
In the citing paper
“For the 'Summary of findings' tables for CSF and pleural fluid, we provide evidence using culture as the reference standard, which is considered the best reference standard for tuberculosis (Lewinsohn 2017).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Lewinsohn 2017
Citations
Cites
Global tuberculosis report (2014)
Gabbasova, L. A., & Who, E. R. E. (2014) · Cited by 12,702
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907847 · Cited by 2,309 · cited 3×
“These assays are promising, but are not yet commercially available [146, 159, 160].”
BackgroundMethodGrading quality of evidence and strength of recommendations for diagnostic tests and strategies
Schünemann, H. J., Oxman, A. D., Brozek, J., Glasziou, P., Jaeschke, R., Vist, G. E., Williams, J. W., Kunz, R., Craig, J., Montori, V. M., et al. (2008) · BMJ · doi:10.1136/bmj.39500.677199.ae · Cited by 1,782
Gandhi, N. R., Moll, A., Sturm, A. W., Pawinski, R., Govender, T., Lalloo, U., Zeller, K., Andrews, J., & Friedland, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69573-1 · Cited by 1,732 · cited 1×
“The emergence of drug-resistant tuberculosis has become apparent over the past 2 decades, and in particular, multidrug-resistant tuberculosis (MDR-TB; resistant to isoniazid and rifampin) and extensively drug-resistant tuberculosis (XDR-TB; resistant to isoniazid and rifampin, plus any fluoroquinolone and at least 1 o…”
BackgroundSelwyn, P. A., Hartel, D., Lewis, V. A., Schoenbaum, E. E., Vermund, S. H., Klein, R. S., Walker, A. T., & Friedland, G. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903023200901 · Cited by 1,574 · cited 1×
“For example, individuals who have a prior latent infection with Mtb (not treated) and then acquire HIV infection will develop TB disease at an approximate rate of 5%–10% per year (in the absence of effective HIV treatment) [18, 19].”
Background(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.4.16141 · Cited by 1,525
(2005) · PsycEXTRA Dataset · doi:10.1037/e545842006-001 · Cited by 1,274
Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes
Woods, G. L., Brown‐Elliott, B. A., Conville, P. S., Desmond, E. P., Hall, G. S., Lin, G., Pfyffer, G. E., Ridderhof, J. C., Siddiqi, S. H., Wallace, R. J., et al. (2011) · Cited by 1,136
Self-citationMolecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis
Mahairas, G. G., Sabo, P. J., Hickey, M. J., Singh, D. C., & Stover, C. K. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.5.1274-1282.1996 · Cited by 1,103
Research works printed but not linked: 8
- World Health Organization, 2015, Global tuberculosis report 2015
- T-SPOT.TB: an aid in the diagosis of tuberculosis infection; package insert for in vitro diagnositic use
- Perez, 2005, Impact of screening for latent TB before initiating anti-TNF therapy in North America and Europe, Ann Rheum Dis, 64, 265
- US Food and Drug Administration, 2008, Medical devices: T-SPOT-TB—P070006
- Forbes, 2008, Laboratory detection and identification of mycobacteria; approved guideline
- Francis J. Curry National Tuberculosis Center and California Department of Public Health, 2008, Drug-resistant tuberculosis: a survival guide for clinicians
- World Health Organization, 2008, Molecular line probe assays for rapid screening of patients at risk of multi-drug resistant tuberculosis (MDR-TB)
- Ena, 1990, The usefulness and limitations of adenosine deaminase in the diagnosis of tubercular pleurisy. A meta-analytical study [in Spanish], Med Clin (Barc), 95, 333
Cited by
Items 301–400 of 992
The Missing Link in Correlates of Protective Tuberculosis Immunity: Recognizing the Infected Cell
Lewinsohn, D. M., & Lewinsohn, D. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.869057 · Cited by 13
Self-citationRecognizing and addressing the challenges of gastrointestinal tuberculosis
Kudu, E., & Danış, F. (2024) · World Journal of Clinical Cases · doi:10.12998/wjcc.v12.i19.3648 · Cited by 13
“But in some cases, despite intensive efforts, it may not always be possible to confirm the diagnosis of TB[39].”
InfluentialWang, Z., Posey, D. L., Brostrom, R. J., Morris, S. B., Marano, N. N., & Phares, C. R. (2022) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2022.01.049 · Cited by 12
Druszczyńska, M., Seweryn, M. T., Wawrocki, S., Pankowska, A., Godkowicz, M., & Kowalewska-Pietrzak, M. (2023) · Vaccines · doi:10.3390/vaccines11020387 · Cited by 12
Vonnahme, L. A., Raykin, J., Jones, M. W. H., Oakley, J., Puro, J. E., Langer, A. J., Aiona, K., Belknap, R., Ayers, T., Todd, J., et al. (2023) · AJPM Focus · doi:10.1016/j.focus.2023.100148 · Cited by 12
Limitations of the MTB/RIF Assay: An Xpert Review of 4 Clinical Cases
Haas, A. L., Ma, A., Pham, J., Verma, P., Malhotra, U., Church, E. C., Narita, M., Escuyer, V. E., & Shakir, S. M. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf132 · Cited by 12
The Case for Retiring the Tuberculin Skin Test
Cruz, A. T., & Reichman, L. B. (2019) · PEDIATRICS · doi:10.1542/peds.2018-3327 · Cited by 12
“IGRAs are now recommended for use for children as young as 2 years of age(1) and are recommended by the Centers for Disease Control and Prevention (CDC) for adults in all situations in which a TST has been done.(2) IGRAs have clear advantages over the TST: improved specificity due to absence of false-positive results…”
MethodHernández, H. A. D., Vázquez-Anaya, G., Miranda-Zazueta, G., & Castro‐Narro, G. (2020) · Annals of Hepatology · doi:10.1016/j.aohep.2020.02.005 · Cited by 13
Ocaña‐Guzmán, R., Téllez-Navarrete, N. A., Preciado-García, M., Ponce-Gallegos, M. A., Buendía-Roldán, I., Falfán‐Valencia, R., & Chávez‐Galán, L. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104793 · Cited by 12
Male Sex Bias in Immune Biomarkers for Tuberculosis
Bothamley, G. H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.640903 · Cited by 12
“Tuberculin Responses Tuberculin responses were grouped by mm of induration as in the ATS guidelines (12).”
BackgroundManagement of Mycobacterium tuberculosis Prosthetic Joint Infection: 2 Cases and Literature Review
Lo, C. K. L., Chen, L., Varma, S., Wood, G. C. A., Grant, J., & Wilson, E. W. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab451 · Cited by 13
“Although the tuberculin skin test was used in cases (19%) from our literature review, it should not be relied upon to diagnose or exclude active infection [3, 65].”
MethodPott's Disease (Tuberculous Spondylitis)
Pintor, I. A., Pereira, F. G., Cavadas, S., & Lopes, P. (2022) · International Journal of Mycobacteriology · doi:10.4103/ijmy.ijmy_2_22 · Cited by 12
Ramos, G. P., Stroh, G. R., Al‐Bawardy, B., Faubion, W. A., Papadakis, K. A., & Escalante, P. (2017) · Gastroenterology · doi:10.1016/s0016-5085(17)32091-7 · Cited by 12
Wu, W., Yang, M., Xu, M., Ding, C., Li, Y., Xu, K., Shen, J., & Li, L. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195695 · Cited by 12
Tuberculosis and interleukin blocking monoclonal antibodies: Is there risk?
Kelsey, A., Chirch, L. M., & Payette, M. J. (2018) · Dermatology Online Journal · doi:10.5070/d3249041425 · Cited by 12
Boukamel, M., Fougère, Y., Gehri, M., Surís, J. C., Rochat, I., Miletto, D., Kyrilli, S., Fouriki, A., & Crisinel, P. A. (2020) · Swiss Medical Weekly · doi:10.4414/smw.2020.20253 · Cited by 12
Stockbridge, E. L., Loethen, A. D., Annan, E., & Miller, T. L. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243102 · Cited by 12
Global emerging resistance in pediatric infections with TB, HIV, and gram-negative pathogens
Enane, L. A., & Christenson, J. C. (2020) · Paediatrics and International Child Health · doi:10.1080/20469047.2020.1853350 · Cited by 12
“Clinical guidelines have been published regarding TB diagnosis and treatment [6,12,14].”
InfluentialQing, P., Lu, C., Liu, Z., Wen, X., Chen, B., Lin, Z., Ma, Y., Zhao, Y., Liu, Y., & Tan, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.652985 · Cited by 12
Retrospective Performance Analyses of over Two Million U.S. QuantiFERON Blood Sample Results
Bi, C., Clark, R. B., Master, R. N., Kapoor, H., Kroll, M. H., Salm, A. E., & Meyer, W. A. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00096-21 · Cited by 12
“other QFT studies (26, 41), and may be due to an unstable immune response and/or an”
BackgroundRunels, T., Ragan, E. J., Ventura, A. S., Winter, M. R., White, L. F., Horsburgh, C. R., Samet, J. H., Saitz, R., & Jacobson, K. R. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-058751 · Cited by 11
Deep learning-based comprehensive review on pulmonary tuberculosis
Bansal, T., Gupta, S., & Jindal, N. (2024) · Neural Computing and Applications · doi:10.1007/s00521-023-09381-4 · Cited by 11
Na, F., Wang, Y., Yang, H. M., Guo, L., Liang, X., Liu, D., & Zhang, R. (2022) · Annals of Medicine · doi:10.1080/07853890.2022.2140452 · Cited by 17
“Pleural biopsy has a better diagnostic performance for detecting pleural TB; however, it is invasive [9,10].”
Diagnosing Pulmonary Tuberculosis in the Elderly
Symes, M. J., Probyn, B., Daneshvar, C., & Telisinghe, L. (2020) · Current Geriatrics Reports · doi:10.1007/s13670-020-00319-5 · Cited by 11
Self-reported Engagement in Care among U.S. Residents with Latent Tuberculosis Infection: 2011–2012
Mancuso, J. D., Miramontes, R., Winston, C. A., Horsburgh, C. R., & Hill, A. N. (2021) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202009-1153oc · Cited by 11
Prevalence of Hepatitis B Virus and Latent Tuberculosis Coinfection in the United States
Wong, R. J., Kaufman, H. W., Niles, J. K., Meyer, W. A., & Chitnis, A. S. (2022) · Journal of Public Health Management and Practice · doi:10.1097/phh.0000000000001536 · Cited by 11
Debulpaep, S., Corbière, V., Lévy, J., Schelstraete, P., Driessche, K. V., Mascart, F., & Mouchet, F. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00291 · Cited by 11
The Health and Economic Benefits of Tests That Predict Future Progression to Tuberculosis Disease
Menzies, N. A., Shrestha, S., Parriott, A. M., Marks, S. M., Hill, A. N., Dowdy, D. W., Shete, P. B., Cohen, T., & Salomon, J. A. (2021) · Epidemiology · doi:10.1097/ede.0000000000001418 · Cited by 9
Osawa, T., Watanabe, M., Morimoto, K., Yoshiyama, T., Matsuda, S., Fujiwara, K., Furuuchi, K., Shimoda, M., Ito, M., Kodama, T., et al. (2023) · CHEST Journal · doi:10.1016/j.chest.2023.09.008 · Cited by 11
Tamura, G., Llano, G., Aristizábal, A., Valencia, J., Sua, L. F., & Fernández‐Trujillo, L. (2024) · Intelligent Systems with Applications · doi:10.1016/j.iswa.2024.200365 · Cited by 16
Shan, Q., Li, Y., Yuan, K., Xiao, Y., Yang, L., & He, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-80072-3 · Cited by 10
“The diagnosis of LTBI lacks the gold standard 2,3 .”
Tuberculin Skin Test Versus the Interferon-γ Release Assays: Out With the Old, In With the New
Starke, J. R. (2019) · PEDIATRICS · doi:10.1542/peds.2019-3021 · Cited by 10
“Agreement between the 2 IGRA tests was high (93% for USborn and 97% for non–US-born children), supporting the common recommendation that 1 IGRA is not preferred over the other.(5,6)”
MethodResultSun, W., Gu, J., Bi, K., Zhang, Y., Shen, M., Wang, Y., & Fan, L. (2021) · Infection · doi:10.1007/s15010-021-01578-w · Cited by 11
“Histological sensitivity of different forms of EPTB has been reported to vary: sensitivity of TBLN (resected biopsy) is from 59 to 88% [25], because granulomatous inflammation may be present in infectious and non-infectious lesions; therefore, the specificity of the diagnosis for TBLN may be low [26].”
BackgroundBorrelia burgdorferi Is a Poor Inducer of Gamma Interferon: Amplification Induced by Interleukin-12
van de Schoor, F. R., Vrijmoeth, H. D., Brouwer, M. A. E., ter Hofstede, H. J. M., Lemmers, H., Dijkstra, H., Boahen, C. K., Oosting, M., Kullberg, B. J., Hovius, J. W., et al. (2022) · Infection and Immunity · doi:10.1128/iai.00558-21 · Cited by 11
“diagnostic tool (91), and studies have suggested similar techniques to discriminate active from past Q-fever using whole blood IFN-g assays (92, 93).”
The Role of Post-Bronchoscopy Sputum Examination in Screening for Active Tuberculosis
Ali, G. A. M., Goravey, W., Howady, F. S., Ali, M., Alshurafa, A., Abdalhadi, A. M., Hajmusa, M., Daghfal, J., Al‐Khal, A., Maslamani, M. A. R. S. A., et al. (2022) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed8010013 · Cited by 10
“Though the evidence base is limited, current guidelines from the American Thoracic Society (ATS) and Infectious Diseases Society of America (IDSA) suggest performing post-bronchoscopy sputum acid-fast bacilli smear and cultures to increase the diagnostic yield [9].”
BackgroundMethodInfluentialMirijello, A., Ritrovato, N., D’Agruma, A., de Matthaeis, A., Pazienza, L., Parente, P., Cassano, D. P., Biancofiore, A., Ambrosio, A., Carosi, I., et al. (2023) · Medicina · doi:10.3390/medicina59020293 · Cited by 10
Sharma, A., Nagalli, S., Varughese, A. T., & Ayvazian, A. M. (2020) · Cureus · doi:10.7759/cureus.6532 · Cited by 15
LaCourse, S. M., Richardson, B. A., Kinuthia, J., Warr, A. J., Maleche‐Obimbo, E., Matemo, D. N., Cranmer, L. M., Escudero, J. N., Hawn, T. R., & John-Stewart, G. C. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-034308 · Cited by 10
Mycobacterial Infections Potentiated by Biologics
Calabrese, C. M., & Winthrop, K. L. (2020) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2020.02.011 · Cited by 12
Rapid discrimination between tuberculosis and sarcoidosis using next-generation sequencing
Chao, Y., Li, J., Gong, Z., Li, C., Ye, M., Hong, Q., Zhao, X., Sun, Y., Chen, Z., Zhang, S., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.05.028 · Cited by 10
Mycobacterium tuberculosis in solid organ transplant donors and recipients
Malinis, M. F., & Koff, A. (2021) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000885 · Cited by 10
Development of a random forest model to classify sarcoidosis and tuberculosis.
Ma, J., Yin, H., Hao, X., Sha, W., & Cui, H. (2021) · PubMed · Cited by 18
Personalised Medicine for Tuberculosis and Non-Tuberculous Mycobacterial Pulmonary Disease
Kumar, K., & Kon, O. M. (2021) · Microorganisms · doi:10.3390/microorganisms9112220 · Cited by 10
Diagnóstico microbiológico actual de la tuberculosis
Alcaide, F. (2017) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2017.06.003 · Cited by 10
Bertoncello, C., Ferro, A. M., Ferraresso, A., Mascarello, M., Fonzo, M., Minascurta, V., Pistellato, I., Cabbia, C., Cocchio, S., Baldovin, T., et al. (2018) · Journal of Travel Medicine · doi:10.1093/jtm/tay020 · Cited by 10
Bazzi, A. M., Abulhamayel, Y., Rabaan, A. A., & Al‐Tawfiq, J. A. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.01.006 · Cited by 10
Vieira, J. L., Foschiera, L., Ferreira, I. C. S., & Chakr, V. C. B. G. (2021) · Jornal Brasileiro de Pneumologia · doi:10.36416/1806-3756/e20200558 · Cited by 13
“Although pleural biopsy offers a better sensitivity profile, it is invasive and not feasible in some settings.(9,10) Consequently, the quantification of pleural fluid biomarkers has become an attractive alternative to pleural biopsy.”
BackgroundMétodos diagnósticos para tuberculose: uma revisão integrativa
Tassinari, E. R., FERREIRA, G. G., Pegoraro, N. B., & Nogueira, K. D. S. (2022) · BioSCIENCE · doi:10.55684/80.s1.8 · Cited by 9
The laboratory investigation of pleural fluids: An update based on the available evidence
Arrigo, C., Aloisio, E., Rovegno, L., Dolci, A., & Panteghini, M. (2023) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/00045632231157547 · Cited by 9
“Nevertheless, only recently the scientific evidence has supported its introduction in the related guidelines.(33,34) In a meta-analysis, which included 174 studies, the determination of ADA in PF showed sensitivity and specificity of 0.”
BackgroundHirabayashi, R., Nakayama, H., Yahaba, M., Yamanashi, H., & Kawasaki, T. (2023) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2023.12.007 · Cited by 10
Imaging of thoracic tuberculosis: pulmonary and extrapulmonary
Pattamapaspong, N., Kanthawang, T., Peh, W., Hammami, N., Bouaziz, M. C., & Ladeb, M. F. (2023) · BJR|Open · doi:10.1093/bjro/tzae031 · Cited by 9
Alshahrani, M., Hakami, M. I., Younis, M. A., Fan, H., Jeraiby, M., & Alraey, Y. (2021) · Saudi Medical Journal · doi:10.15537/smj.2021.42.7.20200797 · Cited by 9
Imtiaz, S., & Batubara, E. (2022) · Annals of Thoracic Medicine · doi:10.4103/atm.atm_487_21 · Cited by 9
“The current guidelines from the American Thoracic Society and the Centre for Disease Control and Prevention[40] recommend the collection of postbronchoscopic sputum samples to enhance the diagnostic yield in smear/sputum‑negative patients.”
InfluentialAmin, M., Yanti, B., Harapan, H., & Mertaniasih, N. M. (2018) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2018.11.002 · Cited by 9
Global tuberculosis prevention: should we start from the beginning?
Sotgiu, G., Goletti, D., & Matteelli, A. (2019) · European Respiratory Journal · doi:10.1183/13993003.01394-2019 · Cited by 9
Lin, S., Chien, J., Chiang, H.-T., Lu, M., Ko, W., Chen, Y., & Hsueh, P. (2019) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2019.07.008 · Cited by 9
Helleberg, M., Cho, D., Ekenberg, C., Sørensen, S. S., Rix, M., Gustafsson, F., Rasmussen, A., Perch, M., Andersen, P. H., Lundgren, J. D., et al. (2020) · Tuberculosis Research and Treatment · doi:10.1155/2020/7636975 · Cited by 9
“WHO guidelines and the Infectious Diseases Society of America recommend screening of high-risk populations for latent TB infection and prescribe preventive therapy [4, 5].”
Chan, T. C. H., Chen, S. P. L., Mak, C. M., Ching, C. K., Luk, K. S., Tsang, Y.-M., & Leung, D. C. W. (2020) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2019-206397 · Cited by 9
Pulmonary tuberculosis: Evaluation of current diagnostic strategy
Gressens, S. B., Billard‐Pomares, T., Boité, H. L., Cruaud, P., Bouchaud, O., Carbonnelle, É., & Mechai, F. (2020) · Infectious Diseases Now · doi:10.1016/j.medmal.2020.10.007 · Cited by 9
Domínguez-Moreno, R., Garcia-Grimshaw, M. A., Medina‐Julio, D., Cantú-Brito, C. G., & González‐Duarte, A. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05693-2 · Cited by 9
Accuracy of Xpert MTB/RIF assay for the diagnosis of tuberculous pleural effusion
Qiu, Y., Chen, Y., Wu, X., Li, Y., Cao, X., Yu, Z.-Y., Lin, M., Li, Q., Chen, J., Yin, X., et al. (2021) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24185 · Cited by 9
Chapter 7: Extra-pulmonary tuberculosis
Barss, L., Connors, W. J. A., & Fisher, D. (2022) · Canadian Journal of Respiratory Critical Care and Sleep Medicine · doi:10.1080/24745332.2022.2036073 · Cited by 25
Rahmati, S., Bahrampour, A., Nasehi, M., Mirzazadeh, A., Ghaderi, H., & Shahesmaeili, A. (2022) · Medical Journal of the Islamic Republic of Iran · doi:10.47176/mjiri.36.112 · Cited by 9
Tuberculin skin test and interferon‐γ release assays: Can they agree?
Santos, J. A., Duarte, R., & Nunes, C. (2022) · The Clinical Respiratory Journal · doi:10.1111/crj.13569 · Cited by 9
Lee, Y. J., Bacchus, M., Schmidt, E. K., Chawla, M. K., Barker, J. N., & Papanicolaou, G. A. (2018) · Transplant Infectious Disease · doi:10.1111/tid.12889 · Cited by 9
Öztürk-Engin, D., & Popescu, C. P. (2019) · Springer eBooks · doi:10.1007/978-3-030-04744-3_8 · Cited by 11
Latent Tuberculosis Screening Cascade for Non–US-Born Persons in a Large Health System
Shapiro, A. E., Gupta, A., Lan, K. F., & Kim, H. N. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad303 · Cited by 8
“Guidelines recommend screening all non–US-born (nUSb) persons from tuberculosis-endemic areas for latent tuberculosis infection (LTBI) and treating if infection is present [5, 6].”
BackgroundEscudero, J. N., Mecha, J., Richardson, B. A., Maleche‐Obimbo, E., Matemo, D. N., Kinuthia, J., John-Stewart, G. C., & LaCourse, S. M. (2023) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiad416 · Cited by 8
Liu, Z., Cheng, L.-P., Pan, H., Wu, X., Lu, F., Cao, J., Wang, L., Wei, W., Chen, H.-Y., Sha, W., et al. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00743-1 · Cited by 8
Latent Tuberculosis Infection Testing Practices in a Large US Integrated Healthcare System
Ku, J. H., Fischer, H. J., Qian, L., Li, K., Skarbinski, J., Shaw, S. F., Bruxvoort, K. J., Lewin, B. J., Spence, B. C., & Tartof, S. Y. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae015 · Cited by 8
Gaensbauer, J. T., Gonzales, B., Belknap, R., Wilson, M. L., & O'Connor, M. E. (2018) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2018.04.034 · Cited by 9
Tuberculosis — United States, 2018
Talwar, A., Tsang, C. A., Price, S. F., Pratt, R. H., Walker, W. L., Schmit, K. M., & Langer, A. J. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15384 · Cited by 8
Lee, C. M., Lee, Y., Kang, S., Kang, C. K., Choe, P. G., Song, K., Park, W. B., Kim, E. S., Jung, S., Kim, H. B., et al. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.05.021 · Cited by 8
Multicenter Analysis of Attrition from the Pediatric Tuberculosis Infection Care Cascade in Boston
Campbell, J. I., Tabatneck, M., Sun, M., He, W. A., Musinguzi, N., Hedt‐Gauthier, B., Lamb, G. S., Domond, K., Goldmann, D. A., Sabharwal, V., et al. (2022) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2022.09.038 · Cited by 8
Caruso, E. C., Mangan, J. M., Maiuri, A., Bouwkamp, B. A., & DeLuca, N. (2023) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7244a2 · Cited by 8
“Overall, U.S. TB case rates have declined during the past 2 decades ( 2 ); however, this trend could stagnate if actions to prevent TB are not implemented by HCPs serving groups experiencing disproportionate risk for TB and progressing from LTBI to TB disease.”
BackgroundMethodInfluentialLi, M., Zhang, D., Yang, Q., Zhao, Z., Zhang, C., Zhou, Y., Bai, Y., Chen, L., Tang, X., Liu, C. H., et al. (2024) · Respiratory Research · doi:10.1186/s12931-024-02837-8 · Cited by 10
“At enrollment, all patients were confirmed by experienced clinicians, based on clinical symptoms, microbiological or radiological evidence [16].”
BackgroundSayyahfar, S., davoodzadeh, F., Hoseini, R., Rahimzadeh, N., & Otukesh, H. (2018) · Pediatric Transplantation · doi:10.1111/petr.13148 · Cited by 8
ARDS from miliary tuberculosis successfully treated with ECMO
Vésteinsdóttir, E., Mýrdal, G., Sverrisson, K., Skarphedinsdottir, S. J., Guðlaugsson, Ó., & Kárason, S. (2019) · Respiratory Medicine Case Reports · doi:10.1016/j.rmcr.2019.01.005 · Cited by 8
“Current guidelines recommend fiberoptic bronchoscopy in sputum negative patients with suspected miliary tuberculosis, and that sampling should include bronchial brushings and/or transbronchial biopsy, especially in critically ill patients [15].”
Goswami, N. D., Mase, S., Griffith, D. E., Bhavaraju, R., Lardizabal, A. A., Lauzardo, M., Chen, L., Wilson, J., Chappelle, C., & Haley, C. A. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz167 · Cited by 8
He, Y., Lyon, C. J., Nguyen, D. T., Liu, C., Sha, W., Graviss, E. A., & Hu, Y. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.01756-20 · Cited by 8
“anatomical site, to obtain diagnostic samples is higher in children than in adults (3).”
BackgroundKan, C. K., Ragan, E. J., Sarkar, S., Knudsen, S., Forsyth, M., Muthaiah, M., Kumar, V., Jenkins, H. E., Horsburgh, C. R., Salgame, P., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240595 · Cited by 8
Hickey, A. J., Cummings, M. J., Zafarí, Z., Louh, I. K., Li, J., & O’Donnell, M. R. (2021) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2021.247 · Cited by 8
Chen, Y., Kuo, Y.-W., Wu, H., Wang, J., & Wang, H. (2021) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2021.12.002 · Cited by 10
Lessons learned from continued TB outbreaks in a high school
Kim, Y. J., Kim, B. K., Choi, H. J., Ryoo, S., Kim, E. S., Chang, Y. S., Kim, H. J., Cha, J. H., Kim, J. H., Shin, C., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188076 · Cited by 8
Yang, Z.-H., Gorden, T., Liu, D.-P., Mukasa, L., Patil, N., & Bates, J. H. (2018) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.17.0413 · Cited by 8
Erol, S., Anar, C. M., Erer, O. F., Biçmen, C., & Aydoğdu, Z. (2018) · PubMed Central · Cited by 8
Ghosh, S., Dronavalli, M., & Raman, S. (2019) · Journal of Paediatrics and Child Health · doi:10.1111/jpc.14701 · Cited by 8
Mycobacteria and immunosuppression
Winthrop, K. L., & Roy, E. E. (2020) · Technical report · doi:10.1016/b978-0-444-64217-2.00005-1 · Cited by 8
He, X., Gao, Y., Liu, Q., Zhao, Z., Deng, W., & Yang, H. (2020) · Gastroenterology Research and Practice · doi:10.1155/2020/2056168 · Cited by 9
“Because the number of bacteria in peritoneal effusion or peritoneal tissue is extremely low, the sensitivities of acid-fast staining, MTB culture, and nucleic acid detection are significantly low to meet clinical needs [7, 25, 26].”
Jones, J. M., Vikram, H. R., Lauzardo, M., Hill, A., Jones, J., Haley, C., Seaworth, B. J., Oldham, S., Brown, M., Gutierrez, F., et al. (2020) · Transplant Infectious Disease · doi:10.1111/tid.13357 · Cited by 8
Riestra, S., Taxonera, C., Zabana, Y., Carpio, D., Beltrán, B., Mañosa, M., Gutiérrez, A., & Acosta, M. B. (2020) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2020.04.006 · Cited by 8
Sullivan, K. E., Bassiri, H., Bousfiha, A. A., Costa‐Carvalho, B. T., Freeman, A. F., Hagin, D., Lau, Y., Lionakis, M. S., Moreira, I., Pinto, J. A., et al. (2017) · Journal of Clinical Immunology · doi:10.1007/s10875-017-0426-2 · Cited by 11
Dugdale, C. M., Zachary, K. C., McEvoy, D. S., Branda, J. A., Courtney, A., Craig, R., Doms, A., Germaine, L., Green, C. V., Gulbas, E., et al. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae253 · Cited by 7
“Given the higher reported sensitivity and specificity of a NAAT as compared with an AFB smear [7], some health care facilities now utilize 2 consecutive NAATs to guide discontinuation of airborne precautions in lieu of 3 AFB smears [9].”
InfluentialMaeda, T., Connolly, M., Thevenet-Morrison, K. N., Levy, P. C., Utell, M. J., Munsiff, S. S., & Croft, D. (2024) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2024.100460 · Cited by 7
“…Health Organization (WHO) [14], American Thoracic Society (ATS) / Infectious Diseases Society of America (IDSA) / Centers for Disease Control (CDC) [15], United States Preventive Services Task Force (USPSTF) [16], European Respiratory Society (ERS) [17], European Society of Clinical Microbiology…”
Alpaydın, A. Ö., Turunç, T., Avkan-Oğuz, V., Eyüboğlu, F. Ö., Tigen, E. T., Hasanoğlu, İ., Aydın, G., Tekce, Y. T., Şenbayrak, S., Kızılateş, F., et al. (2024) · Thoracic research and practice · doi:10.5152/thoracrespract.2024.23110 · Cited by 7
Validation of mNGS results using extensive lab and clinical data
Zhang, Z., & Tian, L. (2025) · BMC Microbiology · doi:10.1186/s12866-025-03908-6 · Cited by 7
“Laboratory investigations include the cultivation of M. tuberculosis and nucleic acid testing for the bacterium [11].”
Yanai, H. A., Ellul, P., Verstockt, B., Greuter, T., Kopylov, U., Casanova, M. J., Dragoni, G., Eder, P., Estevinho, M. M., Abreu, C., et al. (2026) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjag071 · Cited by 14
Tuberculosis in children from diagnosis to decision to treat
Ramos, S. D. S., Gaio, R., Ferreira, F., Leal, J. P., Martins, S., Santos, J. V., Carvalho, I., & Duarte, R. (2017) · Revista Portuguesa de Pneumologia · doi:10.1016/j.rppnen.2017.06.004 · Cited by 9
Park, J. W., Curtis, J. R., Lee, H., Lee, J., Song, Y. W., & Lee, E. B. (2020) · PLoS ONE · doi:10.1371/journal.pone.0244239 · Cited by 7
Fornaro, M., Stano, S., Goletti, D., Semeraro, A., Cantatore, F., Maruotti, N., Colella, S., Abbruzzese, A., Santo, L., Praino, E., et al. (2022) · European Journal of Clinical Investigation · doi:10.1111/eci.13913 · Cited by 8
Metadata
- Authors
- Lewinsohn, D. M., Leonard, M. K., LoBue, P. A., Cohn, D. L., Daley, C. L., Desmond, E., Keane, J., Lewinsohn, D. A., Loeffler, A. M., Mazurek, G. H., O’Brien, R. J., Pai, M., Richeldi, L., Salfinger, M., Shinnick, T. M., Sterling, T. R., Warshauer, D. M., & Woods, G. L.
- Affiliations
- Oregon Health & Science University (US)
- Emory University School of Medicine and
- Centers for Disease Control and Prevention (US)
- Denver Public Health (US)
- National Jewish Health (US)
- California Department of Public Health (US)
- St. James's Hospital (IE)
- Francis J. Curry International TB Center, San Francisco, California;
- FIND (CH)
- McGill University (CA)
- University of Southampton (GB)
- Vanderbilt University (US)
- Wisconsin State Laboratory of Hygiene, Madison, and
- University of Arkansas for Medical Sciences (US)
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-12-08
- Volume
- 64
- Issue
- 2
- Pages
- e1-e33
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC5504475
- OpenAlex
- W2559832962
- Cited by
- 992
- References
- 246
- Citations by year
- 2026: 65 · 2025: 81 · 2024: 91 · 2023: 101 · 2022: 115 · 2021: 142 · 2020: 133 · 2019: 110 · 2018: 96 · 2017: 55 · 2016: 1
- FWCI
- 80.13
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Arrow@dit (Dublin Institute of Technology) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Infectious Diseases › Diagnosis and treatment of tuberculosis
- Keywords
- tuberculosis diagnosis, latent tuberculosis infection, pulmonary tuberculosis, extrapulmonary tuberculosis, Mycobacterium tuberculosis, diagnostic testing, children, adults
- MeSH terms
- Adult, Age Factors, Child, Humans, Mycobacterium tuberculosis, Tuberculosis, Tuberculosis, Pulmonary, Latent Tuberculosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.